William B. Walkup & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.27M Buy
12,858
+184
+1% +$42.9K 1.57% 18
2026
Q1
$2.1M Buy
12,674
+308
+2% +$71.7K 1.25% 22
2025
Q4
$2.56M Sell
12,366
-479
-4% -$94.7K 1.4% 19
2025
Q3
$2.38M Buy
12,845
+70
+0.5% +$12K 1.28% 22
2025
Q2
$1.95M Buy
12,775
+101
+0.8% +$15.5K 1.15% 25
2025
Q1
$2.1M Buy
12,674
+574
+5% +$89.8K 1.28% 21
2024
Q4
$1.75M Sell
12,100
-39
-0.3% -$6.04K 1.11% 25
2024
Q3
$1.97M Sell
12,139
-183
-1% -$29.2K 1.22% 25
2024
Q2
$1.8M Buy
+12,322
New +$1.83M 1.18% 25

Other funds holding JNJ

William B. Walkup & Associates's JNJ Position: Q2 2026 in Review

William B. Walkup & Associates increased its Johnson & Johnson (JNJ) stake by 1.5% in Q2 2026, buying an estimated $42.9K and bringing the position to 12,858 shares worth $3.27M. The position accounts for 1.57% of the portfolio, ranked #18.

William B. Walkup & Associates first reported a position in JNJ in Q2 2024 and has held it in 9 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • William B. Walkup & Associates held 12,858 shares of Johnson & Johnson worth $3.27M as of Q2 2026.
  • William B. Walkup & Associates bought 184 Johnson & Johnson shares in Q2 2026, an estimated $42.9K.
  • Johnson & Johnson made up 1.57% of William B. Walkup & Associates's portfolio in Q2 2026, its #18 holding.
  • William B. Walkup & Associates first reported a position in Johnson & Johnson in Q2 2024 and has held it in 9 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on William B. Walkup & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.